Systematic Review: Efficacy and Safety of Accelerated Induction Regimes in Infliximab Rescue Therapy for Hospitalized Patients with Acute Severe Colitis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Link
http://link.springer.com/content/pdf/10.1007/s10620-018-5407-7.pdf
Reference43 articles.
1. Domenech E, Manosa M, Cabre E. An overview of the natural history of inflammatory bowel diseases. Dig Dis. 2014;32:320–327.
2. Ananthakrishnan AN, McGinley EL, Binion DG, et al. A nationwide analysis of changes in severity and outcomes of inflammatory bowel disease hospitalizations. J Gastrointest Surg. 2011;15:267–276.
3. Hardy TL, Bulmer E. Ulcerative colitis: a survey of ninety-five cases. Br Med Journal. 1933;2:812–815.
4. Brown SR, Haboubi N, Hampton J, George B, Travis SP. The management of acute severe colitis: ACPGBI position statement. Colorectal Dis. 2008;10:8–29.
5. Turner D, Walsh CM, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol. 2007;5:103–110.
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial;The Lancet Gastroenterology & Hepatology;2024-09
2. Predicting Outcome after Acute Severe Ulcerative Colitis: A Contemporary Review and Areas for Future Research;Journal of Clinical Medicine;2024-08-01
3. Modern practical management of acute severe colitis;Indian Journal of Gastroenterology;2024-02
4. Unresolved challenges in acute severe ulcerative colitis;Indian Journal of Gastroenterology;2024-01-08
5. Development and validation of a risk model to predict the progression of ulcerative colitis patients to acute severe disease within one year;Expert Review of Gastroenterology & Hepatology;2023-11-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3